Internal Medicine News - Atacand, vaccinia immune globulin.(NEW & APPROVED)
Novartis Pharma has announced that it has launched Diovan Tablet 160mg, a high-dose preparation of its antihypertensive drug.
Diovan, a selective AT1 receptor blocker, has earned the credibility of Japanese hypertensive patients since its release in 2000. The product meets the patients’ needs for high-dose preparation.
Most Popular
5 Regular Mistakes In Public Speaking
Eight Major Job Trends For 2008
Today’s Best Part-Time Jobs
10 Jobs That Pay $30 An Hour
Five Ways To Successfully Negotiate A Salary
The company expects that the product will help improve the patients’ compliance and increase their life expectancy.
c 2004 Japan Corporate News Network. All rights reserved.
Provided by ProQuest Information and Learning Company. All rights Reserved.
